| 题目 | 发表杂志 | 发表年份 | IF | DOI |
| Case report: Effective Combination Therapy with Afatinib and Anlotinib in Lung Adenocarcinoma with Uncommon EGFR L858M/L861R Mutations | Frontiers in Pharmacology | 2024.11 | 4.4 | 10.3389/fphar.2024.1437086 |
| Single-cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers | Clinical and Translational Medicine | 2024.11 | 10.6 | 10.1002/ctm2.70091 |
| Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK/JAK/STAT axis | Cell Death & Disease | 2024.10 | 9.7 | 10.1038/s41419-024-07074-x |
| Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient | Cell | 2024.10 | 45.6 | 10.1016/j.cell.2024.09.004 |
| Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer | Frontiers in Pharmacology | 2024.07 | 4.4 | 10.3389/fphar.2024.1359403 |
| tRNA m1A modification regulate HSC maintenance and self-renewal via mTORC1 signaling | Nature Communications | 2024.6 | 14.7 | 10.1038/s41467-024-50110-9 |
| Remodeling ceramide homeostasis promotes functional maturation of human pluripotent stem cell-derived β cells | Cell Stem Cell | 2024.06 | 19.8 | 10.1016/j.stem.2024.04.010 |
| Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis | The New England Journal of Medicine | 2024.04 | 96.3 | 10.1056/NEJMoa2313812 |
| The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma | Scientific Reports | 2024.04 | 4.6 | 10.1038/s41598-024-59130-3 |
| The efficient generation of functional human hepatocytes from chemically induced pluripotent stem cells | Cell Proliferation | 2024.02 | 5.9 | 10.1111/cpr.13540 |
| Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer | Frontiers in Immunology | 2023.12 | 8.8 | 10.3389/fimmu.2023.1263633 |
| Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer | J Leukoc Biol | 2023.11 | 5.5 | 10.1093/jleuko/qiad138 |
| PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells | Npj Precision Oncology | 2023.05 | 10.1 | 10.1038/s41698-023-00384-x |
| A single cell-based computational platform to identify chemical compounds targeting desired sets of transcription factors for cellular conversion | Stem Cell Reports | 2023.01 | 5.9 | 10.1016/j.stemcr.2022.10.013 |
| Implantation underneath the abdominal anterior rectus sheath enables effective and functional engraftment of stem-cell-derived islets | Nature Metabolism | 2023.01 | 19.9
| 10.1038/s42255-022-00713-7 |
| YY1 safeguard multidimensional epigenetic landscape associated with extended pluripotency | Nucleic Acids Research | 2022.11 | 16.7 | 10.1093/nar/gkac230 |
| Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial | JAMA Oncology | 2022.07 | 33.0 | 10.1001/jamaoncol.2022.2719. |
| Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC) | Cell Death and Disease | 2022.07 | 9.7 | 10.1038/s41419-022-05057-4 |
| Dysregulated Th1 cells in lung squamous cell carcinoma | J Leukoc Biol | 2022.06 | 5.5 | 10.1002/JLB.1MA0422-208R |
| PEAC: An Ultrasensitive and Cost-Effective MRD Detection System in Non-small Cell Lung Cancer Using Plasma Specimen | Frontiers in Medicine | 2022.05 | 5.1 | 10.3389/fmed.2022.822200 |
| Chemical reprogramming of human somatic cells to pluripotent stem cells | Nature | 2022.04 | 69.5
| 10.1038/s41586-022-04593-5 |
| Human Pluripotent Stem Cell-derived Islets Ameliorate Diabetes in Nonhuman Primates | Nature Medicine | 2022.02 | 87.2 | 10.1038/s41591-021-01645-7 |
| Neoadjuvant PD-1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung | Thoracic Cancer | 2022.02 | 3.2 | 10.1111/1759-7714.14280 |
| Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade | Oncoimmunology | 2022.01 | 7.7 | 10.1080/2162402X.2022.2025668 |
| Transcriptomic and mutational analysis discovering distinct molecular characteristics among Chinese thymic epithelial tumor patients | Frontiers in Oncology | 2021.09 | 5.7 | 10.3389/fonc.2021.647512 |
| Safety but limited efficacy of ensartinib in ros1-positive non-small cell lung cancer: A single-arm, multicenter phase II study | Journal of Thoracic Oncology | 2021.07 | 20.1 | 10.1016/j.jtho.2021.06.023 |
| Decoding the Evolutionary Response to Ensartinib in ALK-Positive Non-Small-Cell Lung Cancer Patients by Dynamic Circulating Tumor DNA Sequencing | Journal of Thoracic Oncology | 2021.01 | 20.1 | 10.1016/j.jtho.2021.01.1615 |
| Integrated Multiomics Analyses Revealing Different Molecular Profiles Between Early- and Late-Stage Lung Adenocarcinoma | Frontiers in Oncology | 2021.01 | 5.7 | 10.3389/fonc.2021.746943 |
| Potential predictive value of serum targeted metabolites and concurrently mutated genes for EGFR-TKI therapeutic efficacy in lung adenocarcinoma patients with EGFR sensitizing mutations | American Journal of Cancer Research | 2020.12 | 5.9 | PMID: 33414999 |
| Construction of a Human Cell Landscape at Single-cell Level | Nature | 2020.03 | 69.5 | 10.1038/s41586-020-2157-4 |
| Generation of human hepatocytes from extended pluripotent stem cells | Cell Research | 2020.03 | 46.3 | 10.1038/s41422-020-0293-x |
| A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts | Cell Research | 2019.07 | 46.3 | 10.1038/s41422-019-0196-x |
| Long-term functional maintenance of primary human hepatocytes in vitro | Science | 2019.04 | 63.7 | 10.1126/science.aau7307 |
| Identification of a novel WNK1–ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib | Lung Cancer | 2019.03 | 6.1 | 10.1016/j.lungcan.2018.12.011 |
| Efficacy, safety, and biomarker analysis of ensartinib (X-396) in crizotinib-resistant ALK-positive non-small-cell lung cancer (NSCLC): results from a multicenter, phase II trial | Lancet Respiratory Medicine | 2019.01 | 102.6 | 10.1016/S2213-2600(19)30252-8 |
| Nonsmall cell lung cancer with rare exon 7 p.A289V mutation in the EGFR gene responds to Icotinib treatment | Medicine | 2018.12 | 1.9 | 10.1097/MD.0000000000013809 |
返回列表 
0571-88610677
marketing@repugene.com
浙江省杭州市余杭区联创街188号 贝达梦工场D座7-10层